DRUGS related term(s) Crime

Addresses

Advances in Veterinary Medicine: Senator Jeffords, S8942 [26JY]

Amendments

Crime: reduce violent gang crime and protect law-abiding citizens and communities from violent criminals (H.R. 1279), H3144, H3146, H3147, H3148, H3149, H3150, H3152, H3153, H3154 [11MY]

———reduce violent gang crime and protect law-abiding citizens and communities from violent criminals (H.R. 1279), consideration (H. Res. 268), H3132 [11MY]

Articles and editorials

'91 Memo Warned of Mercury in Shots, H482 [9FE]

Avian Flu Virus Could Hide in Ducks, S8447 [19JY]

Baseball Needs Cleaned-Up Hitters, S7907 [1JY]

Belize—Small Country, Big Progress, E1568 [21JY]

Bigger Than the Social Security Crisis—Wasteful Spending on Prescription Drugs, E1162 [8JN]

Bird Flu Drug Rendered Useless—Chinese Chickens Given Medication Made for Humans, S8448 [19JY]

Brazil Mulls Drug Patent Theft as an AIDS Antidote, E1436 [1JY]

Bush Should Feel Doctors' Pain, E692 [19AP]

California Helped Pay for 137 Sex Offenders' Viagra—State Agencies Directed To Stop Providing Such Drugs to Ex-Convicts, H5037 [23JN]

Colombia's Capitulation, H5974 [19JY]

Congress, on Drugs—Helping Their Friends in the Pharmaceutical Industry, S14143 [20DE]

Deadly Flu Strain Shows Up in Migratory Birds—Scientists' Discovery Gives Rise to Fears the Virus Could Spread Beyond East Asia, S8448 [19JY]

Deadly Immunity, H5074-H5077 [23JN]

Drug Makers Don't Need Gift, S14143 [20DE]

Drug Scourge Creates Its Own Form of Orphan, S8547 [20JY]

Drug War Fails To Dent U.S. Supply, H5287 [28JN]

Exhale, Stage Left—At 61, Longtime Marijuana Lobby Leader Keith Stroup Is Finally Leaving the Joint, E102 [26JA]

Financing Drug Research—What Are the Issues?, E1159 [8JN]

Learn From Past Vaccines—Drug Firms Don't Deserve Virtually Unlimited Protection Against Vaccine Lawsuits, S14145 [20DE]

Little Round Faces of Meth, S8547 [20JY]

Meth Epidemic Strikes Ohio, S9904-S9906 [12SE]

Naughty Pursuit of Secrecy, S14144 [20DE]

New York's HIV Experiment, E37 [6JA]

Pandering Pandemic, S14144 [20DE]

Police Bust Meth Superlab, S6473 [14JN]

Polio and Rotary, S3448 [12AP]

Richman? Poorman? Beggarman? Thief?, E1435 [1JY]

Seniors Try To Decipher Drug Options, H9935 [7NO]

South American Drug Cartels Lured to West Africa, E1729 [29JY]

Stealth Liability Provision, S14142 [20DE]

Threat Worse Than Terror, S11960 [27OC]

Trading on Fear To Pass Vaccine Legislation Is Wrong, S14143 [20DE]

U.S. Blocks Drugs Sent From Canada, H1329 [10MR]

Unprepared for a Flu Pandemic, S8448 [19JY]

Vaccine Makers—Lawmakers Service People, Not Drug Companies, S14143 [20DE]

Vaccines and Accountability—Bush's Proposal To Shield Avian-Flu Vaccine Makers From Liability Invites Health Problems, S14145 [20DE]

Vaccines Come With Risk, S14143 [20DE]

Vaccines—Shot in the Dark, S14144 [20DE]

Veterans Angered by Official's Comments, H517 [9FE]

Wrong-Way Immunity, S14145 [20DE]

Your Dietary Supplements—Under Attack Again, E1455 [11JY]

Bills and resolutions

Advertising: prohibit as indecent the broadcasting of any advertisement for a medication for the treatment of erectile dysfunction (see H.R. 1420), H1693 [17MR]

———provide discounts to Medicaid and other Federal programs for the advertising costs of certain prescription drugs and ensure that these drugs are prescribed based on health needs rather than marketing (see S. 1128), S6021 [26MY]

Afghanistan: eradicate poppy plant (see H.R. 1437), H1694 [17MR]

Anabolic Steroid Control Act: technical corrections (see S. 893), S4184 [25AP]

Armed Forces: prohibit requirement of anthrax and smallpox immunizations without members' consent and correct records of those previously punished for refusing such vaccines (see H.R. 514), H347 [2FE]

Business and industry: provide incentives for investment in research and development of new medicines and to enhance access to new medicines (see H.R. 417), H235 [26JA]

Camarena, Enrique (Kiki): tribute (see S. Res. 73), S2245 [8MR] (see H. Res. 141), H1024 [8MR]

Centers for Medicare & Medicaid Services: tribute for demonstration project to assess quality of care of cancer patients undergoing chemotherapy (see H. Res. 261), H2978 [4MY]

Children and youth: provide comprehensive services for children who have been removed from environments in which methamphetamines are unlawfully manufactured, distributed, or dispensed (see H.R. 2335), H3260 [12MY]

China, People's Republic of: adhere to internationally recognized health standards by prohibiting use of antiviral medication to protect livestock (see H. Res. 377), H6381 [22JY]

Cocaine: adjust penalties for powder cocaine and crack cocaine offenses (see H.R. 48), H73 [4JA] (see H.R. 1501), H1844 [6AP]

Consumers: establish fairer pricing for prescription drugs for individuals without access to discounted prices (see H.R. 1655), H2101 [14AP]

Contraceptives: require equitable coverage of drugs, devices, and services under health insurance plans (see S. 1214), S6299 [9JN] (see H.R. 4651), H13188 [22DE]

Controlled Substances Act: amend relative to distribution of pseudoephedrine (see H.R. 1056), H940 [2MR]

———amend relative to methamphetamine (see H.R. 3756), H7861 [13SE]

———amend relative to regulation of ephedrine alkaloids (see H.R. 1083), H981 [3MR] (see H.R. 1378), H1691 [17MR]

———exclude industrial hemp from the definition of marijuana (see H.R. 3037), H4984 [22JN]

———prohibit third-party Internet sales sites from posting offers to sell controlled substances (see H.R. 3608), H7561 [28JY]

———provide increased penalties for methamphetamine traffickers (see H.R. 3755), H7860 [13SE]

Courts: provide an affirmative defense for medical use of marijuana in Federal criminal trials occuring in States with medical marijuana use laws (see H.R. 4272), H10144 [9NO]

———provide civil liability for illegal manufacturers and distributors of controlled substances for the harm caused by the use of those controlled substances (see H.R. 2348), H3261 [12MY]

Crack cocaine: eliminate certain mandatory minimum penalties for offenses (see H.R. 2456), H3555 [18MY]

Crime: allow for the prosecution of members of criminal street gangs (see S. 1322), S7520 [28JN]

———conduct study evaluating correlations between methamphetamine crimes and identity theft crimes (see S. 884), S4108 [21AP] (see H.R. 3325), H5963 [18JY]

———encourage the President to convene an international conference to develop more effective means to deal with growing threat of methamphetamine and synthetic drug precursor chemicals (see H. Res. 566), H10909 [17NO]

———enhance Federal penalties for illegal production, distribution, and use of methamphetamines and other controlled substances, and provide residential substance abuse treatment programs for State and Federal prisoners (see H.R. 3513), H7557 [28JY]

———link recidivist penalties for certain drug crimes (see S. 344), S1260 [10FE]

———provide a minimum mandatory prison sentence for manufacturing methamphetamine on properties where children reside (see H.R. 1395), H1692 [17MR]

———provide an increased penalty for endangering a child while illegally manufacturing a controlled substance (see H.R. 1616), H1969 [13AP]

———provide grants to States to combat methamphetamine abuse (see S. 102), S144 [24JA] (see S. 430), S1622 [17FE] (see H.R. 313), H193 [25JA] (see H.R. 3324), H5963 [18JY]

———provide penalties for open air drug markets (see H.R. 1758), H2469 [21AP]

———reduce criminal gang activities (see S. 155), S436 [25JA] (see H.R. 970), H795 [17FE]

———reduce violent gang crime and protect law-abiding citizens and communities from violent criminals (see H.R. 1279), H1416 [14MR]

———reduce violent gang crime and protect law-abiding citizens and communities from violent criminals (H.R. 1279), consideration (see H. Res. 268), H3112 [10MY]

———respond to the illegal production, distribution, and use of methamphetamines (see S. 103), S144 [24JA] (see H.R. 13), H71 [4JA] (see H.R. 314), H193 [25JA] (see H.R. 3889), H8341 [22SE]

Dept. of Commerce: issue regulations requiring testing for steroids and other performance-enhancing substances for certain sports associations engaged in interstate commerce (see H.R. 1862), H2550 [26AP] (see H.R. 3084), H5361 [28JN]

Dept. of Defense: require emergency contraception to be available at all military health care treatment facilities (see H.R. 2635), H4073 [25MY]

Dept. of Education: review and revise guidelines relating to the ``Principles of Effectiveness'' criteria to improve State and local drug-use prevention programs and activities (see H.R. 3655), H7672 [6SE]

Dept. of HHS: authorize to negotiate prices for Medicare outpatient prescription drugs and include prices charged to certain Federal agencies in determining best price for Medicaid outpatient drugs (see H.R. 2200), H3055 [5MY]

———establish Office of Correctional Public Health (see H.R. 2737), H4141 [26MY]

———establish the National Vaccine Authority (see H.R. 4396), H11033 [18NO]

———promulgate regulations for the reimportation of prescription drugs (see S. 109), S144 [24JA]

———revise minimum allotments under the Projects for Assistance in Transition From Homelessness (PATH) Program (see S. 319), S1115 [8FE] (see H.R. 2826), H4296 [8JN]

Dept. of HUD: reauthorize the Public Housing Drug Elimination Program (see H.R. 790), H586 [14FE]

Dept. of Justice: authorize export of certain narcotic drugs and nonnarcotic controlled substances to a country for subsequent export from that country to another country, if certain conditions are met (see S. 1395), S8217 [13JY] (see H.R. 184), H77 [4JA]

———establish a National Methamphetamine Information Clearinghouse (see S. 2046), S13161 [17NO]

———improve drug court grant program (see H.R. 3739), H7860 [13SE]

Dept. of Veterans Affairs: conduct a study of the accuracy of expiration dates on certain prescription drugs maintained by the Dept. (see H.R. 1149), H1023 [8MR]

———permit Medicare-eligible veterans to receive an outpatient medication benefit (see S. 614), S2644 [14MR]

———require filling of prescriptions for drugs and medicines written by private physicians (see H.R. 2379), H3331 [16MY]

Developing countries: accelerate efforts to develop vaccines for diseases primarily affecting developing countries (see S. 1698), S10037 [14SE] (see H.R. 3781), H7949 [14SE]

Diseases: anniversary of development of Salk polio vaccine (see S. Res. 101), S3278 [6AP] (see H. Res. 208), H1895 [12AP]

———establish programs and activities to increase influenza vaccination rates through the provision of free vaccines (see S. 2112), S13659 [15DE]

———improve and secure an adequate supply of influenza vaccine (see S. 1828), S11212 [6OC]

———improve preparation for an influenza pandemic, including an avian influenza pandemic (see S. 969), S4547 [28AP] (see S. 1821), S11130 [5OC] (see H.R. 3369), H6204 [20JY] (see H.R. 4062), H8846 [17OC] (see H.R. 4245), H9962 [7NO] (see H.R. 4603), H12048 [16DE]

———promote initiatives to develop an HIV vaccine (see S. Res. 42), S1050 [7FE] (see H. Res. 286), H3556 [18MY]

———provide assistance to countries to combat tuberculosis, malaria, and other infectious diseases (see S. 950), S4546 [28AP]

———provide for emergency distributions of influenza vaccine (see H.R. 4358), H10908 [17NO]

Drug testing: prohibit the manufacture, marketing, sale, or shipment of products designed to assist in defrauding a drug test (see H.R. 2802), H4295 [8JN]

FDA: determine whether to allow marketing of emergency-contraceptive drug Plan B as a prescription drug for women 15 or younger and a nonprescription drug for women 16 or older (see H.R. 4229), H9641 [3NO]

———ensure autonomy and eliminate conflicts-of-interest relative to drug company fees and advisory panels, improve postmarket drug safety, regulate off-label uses, and clarify liability for approved drugs (see H.R. 2090), H2976 [4MY]

———improve ability to ensure drug safety (see S. 930), S4398 [27AP] (see H.R. 4429), H11034 [18NO]

———prohibit the approval of any drug that infringes the right to life (see H.R. 3553), H7558 [28JY]

———reaffirm position on sanitary and phytosanitary guidelines for vitamin and mineral food supplements adopted by the Codex Alimentarius Commission (see H. Res. 562), H10909 [17NO]

———require prior approval of advertisements for prescription drugs and restricted medical devices (see H.R. 3696), H7812 [8SE]

———withdraw approved application for the drug known as RU-486 and review process by which the FDA approved such drug (see S. 511), S2004 [3MR] (see H.R. 1079), H981 [3MR]

Federal aid programs: improve provision of discounts on drug purchases for certain safety net providers (see H.R. 4544), H11653 [14DE]

———prohibit Federal payment or reimbursement for drugs prescribed for the treatment of sexual or erectile dysfunction (see S. 1113), S5851 [24MY] (see H.R. 3566), H7559 [28JY]

———prohibit Federal payment or reimbursement for drugs prescribed to sex offenders for the treatment of sexual or erectile dysfunction (see S. 1126), S5921 [25MY] (see H.R. 2814), H4295 [8JN]

———public participation in establishing locations of substance abuse treatment group homes (see H.R. 3516), H7557 [28JY]

Federal Food, Drug, and Cosmetic Act: amend relative to dietary supplements (see H.R. 3156), H5600 [30JN]

———amend relative to drug advertising (see H.R. 3950), H8642 [29SE]

———create a three-tiered approval system for drugs, biological products, and devices that is responsive to the needs of seriously ill patients (see S. 1956), S12353 [3NO]

———enhance criminal penalties for certain violations involving concealment of evidence of a serious adverse drug experience (see H.R. 870), H719 [16FE]

———establish recall authority for drugs and increase criminal penalties for sale or trade of knowingly adulterated or misbranded prescription drugs (see S. 1978), S12606 [9NO] (see H.R. 2345), H3261 [12MY]

———establish recall authority for drugs and increase criminal penalties for sale or trade of prescription drugs knowingly adulterated or misbranded (see H.R. 1396), H1692 [17MR]

———establish requirements to allow sale of prescription drugs over the Internet (see S. 399), S1513 [16FE] (see H.R. 840), H717 [16FE]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (see S. 742), S3358 [7AP] (see H.R. 2562), H3892 [24MY]

———prohibit sale or trade of prescription drugs that were knowingly adulterated or misbranded (see H.R. 2600), H3893 [24MY]

———reduce human exposure to mercury through vaccines (see S. 1422), S8487 [19JY] (see H.R. 881), H791 [17FE]

Federal Office of Steroids Testing Enforcement and Prevention: establish (see H.R. 3942), H8642 [29SE]

Foreign countries: remove all embargoes on food, medicine, and medical supplies (see H.R. 1527), H1845 [6AP]

Foreign trade: provide for importation of pharmaceutical products under a compulsory license as provided for under the World Trade Organization (see H.R. 4392), H11033 [18NO]

Government regulations: eliminate safe-harbor exception for certain packaged pseudoephedrine products used in manufacturing methamphetamine (see H.R. 1350), H1621 [16MR] (see H.R. 1446), H1694 [17MR]

———establish certain restrictions on drugs containing isotretinoin, including the drug marketed as Accutane (see H.R. 2956), H4655 [16JN]

———protect the public from unsafe importation of prescription drugs and from counterfeit prescription drugs (see S. 184), S574 [26JA] (see H.R. 753), H582 [10FE]

———transfer ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances (see H.R. 3568), H7559 [28JY] (see H.R. 3955), H8642 [29SE]

———withdraw the drug OxyContin from the commercial market (see H.R. 2195), H3054 [5MY]

Health: conduct vaccine awareness campaign, ensure sufficient vaccine supply, prepare for pandemic or epidemic, and encourage vaccine production capacity relative to influenza (see S. 375), S1413 [15FE] (see H.R. 628), H410 [8FE] (see H.R. 813), H628 [15FE]

———eliminate price cap applicable to purchase of influenza vaccines and establish a tax credit to encourage vaccine production capacity (see S. 96), S144 [24JA]

———establish reasonable legal reforms that will facilitate the manufacture of vital, life-saving vaccines (see H.R. 650), H411 [8FE]

———improve accessibility to and administration of immunizations against vaccine-preventable diseases, including influenza (see S. 1527), S9284 [28JY] (see H.R. 3502), H7556 [28JY]

———improve accessibility to immunizations against vaccine-preventable diseases, study Medicare and Medicaid influenza immunization usage, and amend Federal employee immunization services (see H.R. 3598), H7560 [28JY]

———improve patient safety and reduce incidence of medical errors (see S. 544), S2244 [8MR] (see H.R. 3205), H5739 [12JY]

———include dehydroepiandrosterone as an anabolic steroid (see S. 1137), S6021 [26MY] (see H.R. 3937), H8513 [28SE]

———make antitrust laws apply to negotiations between groups of independent pharmacies and health plans and health insurance issuers in the same manner as collective bargaining by labor organizations (see H.R. 1671), H2102 [14AP]

———national policy to provide health care and reform insurance procedures (see S. 16), S142 [24JA]

———permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (see H.R. 2792), H4295 [8JN]

———promote a culture of safety within the health care system through the establishment of a National Medical Error Disclosure and Compensation Program (see S. 1784), S10594 [28SE]

———provide a drug discount program for individuals without prescription drug coverage (see H.R. 3956), H8643 [29SE]

———require notification by manufacturers before discontinuing production of a vaccine and develop a national vaccine stockpile (see S. 226), S738 [1FE]

Health care facilities: allow qualifying children's hospitals to participate in the 340B drug discount program (see H.R. 4036), H8808 [7OC]

———implement computerized order entry systems in hospitals and skilled nursing facilities to reduce medication errors and increase efficiency (see H.R. 3607), H7561 [28JY]

———provide for public disclosure of charges for certain hospital and ambulatory surgical center services and drugs (see H.R. 3139), H5599 [30JN]

———provide for public disclosure of charges for certain hospital services and drugs (see S. 1827), S11212 [6OC]

Health care professionals: clarify responsibilities of a pharmacy when a staff pharmacist refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions (see S. 809), S3653 [14AP] (see H.R. 1539), H1850 [8AP] (see H.R. 1652), H2101 [14AP]

———educate concerning substance use disorders and addiction (see S. 538), S2148 [7MR] (see H.R. 1789), H2471 [21AP]

———ensure integrity in the operation of pharmacy benefit managers (see H.R. 1669), H2102 [14AP]

———establish electronic systems in each State for practitioner monitoring of the dispensing of certain controlled substances (see H.R. 1132), H983 [3MR]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (see S. 45), S143 [24JA] (see H.R. 869), H718 [16FE]

Higher Education Act: repeal provisions prohibiting persons convicted of drug offenses from receiving student financial assistance (see H.R. 1184), H1263 [9MR]

Hurricanes: temporarily suspend laws that deny certain Federal benefits, grants, and licenses to victims of Hurricanse Katrina or Rita due to convictions for certain drug crimes (see H.R. 4169), H9362 [27OC] (see H.R. 4213), H9555 [2NO]

Immigration: bar admission and facilitate removal of alien terrorists and their supporters, drug traffickers, and other illegal or criminal aliens and reform the visa and legal immigration systems (see H.R. 688), H521 [9FE]

India: provide assistance to combat HIV/AIDS (see S. 674), S2995 [17MR] (see H.R. 1408), H1693 [17MR]

Information services: expand the scope of information required for the data bank on clinical trials for drugs (see H.R. 3196), H5602 [30JN]

Insurance: provide nondiscriminatory coverage of substance abuse treatment services under private group and individual health coverage (see S. 803), S3653 [14AP] (see H.R. 1258), H1370 [10MR]

———require comprehensive coverage for childhood immunizations (see H.R. 277), H137 [6JA]

Japan: urge honoring of commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals (see S. Con. Res. 67), S13362 [18NO] (see H. Con. Res. 311), H11220 [7DE]

Law enforcement: ensure adequate funding is provided for certain high intensity drug trafficking areas (see H.R. 812), H628 [15FE]

———increase evidentiary standard required to convict a person for a drug offense and require screening of law enforcement officers or others acting under color of law participating in drug task forces (see H.R. 2620), H4072 [25MY]

———prevent illegal importation of controlled substances (see S. 400), S1513 [16FE]

———protect vulnerable persons from drug trafficking (see H.R. 1528), H1845 [6AP]

———provide for designation and funding of high intensity methamphetamine abuse and trafficking areas (see H.R. 1055), H940 [2MR]

———provide for research on and standards for remediation of closed methamphetamine production laboratories (see S. 2019), S12949 [16NO] (see H.R. 798), H627 [15FE]

———require a portion of Federal forfeiture funds be used to clean up methamphetamine laboratories (see S. 259), S886 [2FE]

———treat drug offenses involving crystal methamphetamine similarly to drug offenses involving crack cocaine (see S. 1361), S7820 [30JN]

Marijuana: allow for medicinal use in accordance with State laws (see H.R. 2087), H2976 [4MY]

Medicaid: anniversary (see S. Con. Res. 49), S9469 [29JY] (see H. Con. Res. 215), H6327 [21JY]

———extend prescription drug rebate program to enrollees of managed care organizations (see S. 1585), S9467 [29JY]

———provide health information technology grants to States and reduce number of medical and medication errors, unnecessary hospitalizations, infections, and inappropriate care (see H.R. 4142), H9102 [25OC]

———provide public disclosure of average manufacturer prices and best prices for prescription drugs (see H.R. 3546), H7558 [28JY]

———require drug manufacturers to report the average manufacturer price and the best price of authorized generic drugs and any other drugs sold under a certain new drug application to the Dept. of HHS (see S. 1903), S11665 [20OC]

———require drug utilization review programs to deny coverage of erectile dysfunction drugs for individuals registered (or required to be registered) as sex offenders (see H.R. 2648), H4138 [26MY]

———require States that provide prescription drug coverage to cover drugs that treat obesity (see H.R. 286), H137 [6JA]

Medicare: assure cost credibility of the prescription drug benefit (see H.R. 729), H523 [9FE]

———condition the payment of employer prescription drug subsidies on the maintenance of current prescription drug benefits (see H.R. 655), H411 [8FE]

———contain costs of prescription drug program (see S. 581), S2383 [9MR] (see H.R. 918), H793 [17FE]

———continue Medicaid prescription drug coverage to dual-eligible beneficiaries for a certain period while allowing part D benefits to be implemented as scheduled (see S. 566), S2245 [8MR] (see H.R. 1144), H1023 [8MR]

———coverage of, as supplies for the injection of insulin, home needle destruction devices and the disposal of needles and lancets through a sharps-by-mail or similar program (see H.R. 2841), H4355 [9JN]

———coverage of immunosuppressive drugs for beneficiaries who receive an organ transplant (see S. 173), S573 [26JA]

———coverage of immunosuppressive drugs for beneficiaries who receive an organ transplant without regard to when the transplant was received (see H.R. 3633), H7612 [29JY]

———coverage of infertility treatment services for certain disabled individuals (see H.R. 2758), H4186 [7JN]

———delay implementation of prescription drug benefit for individuals who are not lowest-income subsidy eligible individuals (see H.R. 3870), H8340 [22SE]

———deliver a meaningful benefit and lower prescription drug prices (see S. 345), S1260 [10FE] (see S. 873), S4108 [21AP] (see H.R. 752), H582 [10FE]

———deliver a meaningful benefit and lower prescription drug prices (H.R. 752), consideration (see H. Res. 584), H11109 [6DE]

———ensure that prescription drug benefits have no impact on benefits under other Federal programs (see S. 1179), S6154 [7JN] (see H.R. 2746), H4186 [7JN]

———establish criminal penalties for defrauding individuals relative to enrollment in a prescription drug plan (see H.R. 4406), H11033 [18NO]

———exclude coverage of drugs prescribed for treatment of impotence (see H.R. 712), H522 [9FE]

———extend implementation of prescription drug program (see H.R. 3940), H8642 [29SE]

———extend initial enrollment period for prescription drug benefits, waive penalties for late enrollment, and provide other additional beneficiary protections (see H.R. 4410), H11034 [18NO]

———extend initial enrollment period for prescription drug benefits and waive penalties for late enrollment (see H.R. 4399), H11033 [18NO]

———improve (see S. 18), S142 [24JA]

———improve accountability in the Medicare Advantage and prescription drug programs (see H.R. 4103), H9042 [20OC]

———improve coordination of prescription drug coverage under retiree plans and State pharmaceutical assistance programs with Medicare drug benefits (see H.R. 152), H76 [4JA]

———improve coordination of prescription drug coverage under State pharmaceutical assistance programs with Medicare drug benefits (see S. 764), S3481 [12AP] (see H.R. 1572), H1894 [12AP]

———improve voluntary prescription drug benefit and provide greater access to affordable pharmaceuticals (see H.R. 4395), H11033 [18NO]

———negotiate for lower prices for prescription drugs (see S. 813), S3734 [15AP]

———negotiate for lower prices for prescription drugs, eliminate gap in coverage of prescription drug benefits, and promulgate regulations for the reimportation of prescription drugs (see H.R. 1626), H1969 [13AP]

———permit negotiation of fair prices for, and allow the reimportation of, prescription drugs (see S. 239), S738 [1FE]

———permit the Dept. of HHS to enter into direct negotiations to promote the best prices for beneficiaries (see H.R. 376), H233 [26JA]

———permit the Dept. of HHS to enter into direct negotiations to promote the best prices for beneficiaries (H.R. 376), consideration (see H. Res. 267), H3055 [5MY]

———prevent a decrease in benefits resulting from part D premiums increases (see H.R. 3637), H7612 [29JY]

———prohibit the telemarketing of prescription drug and Advantage plans to beneficiaries (see S. 1798), S10724 [29SE]

———protect enrollees eligible for prescription drug benefit coverage from abusive marketing practices (see H.R. 4645), H12289 [18DE]

———provide additional beneficiary protections (see H.R. 2487), H3693 [19MY]

———provide beneficiaries prescription drugs at reduced prices (see H.R. 2685), H4140 [26MY]

———provide beneficiaries with access to prescription drugs at Federal Supply Schedule prices (see H.R. 4610), H12049 [16DE] (see H.R. 4652), H13189 [22DE]

———provide continued coverage for immunosuppressive drugs furnished to beneficiaries that have received an organ transplant and whose coverage would otherwise expire (see H.R. 2051), H2879 [3MY]

———provide extended and additional protection to beneficiaries enrolled in prescription drug benefit plans (see S. 1841), S11212 [6OC] (see H.R. 3861), H8340 [22SE]

———provide extended and additional protection to beneficiaries enrolled in prescription drug benefit plans (H.R. 3861), consideration (see H. Res. 585), H11109 [6DE]

———provide extended and additional protections to certain beneficiaries (see S. 2168), S14317 [21DE]

———provide for negotiation of fair prices for prescription drugs (see S. 123), S145 [24JA] (see S. 445), S1623 [17FE]

———provide for public disclosure of prices for hospital and ambulatory surgical center procedures and drugs (see H.R. 1362), H1690 [17MR]

———provide incentives to physicians for writing electronic prescriptions (see S. 1910), S11768 [24OC]

———remove exclusion of benzodiazepines from required coverage under the prescription drug program (see H.R. 3151), H5600 [30JN]

———remove prescription drug benefit late enrollment penalty and extend the initial enrollment period (see H.R. 4557), H11879 [15DE]

———repeal Medicare Advantage Regional Plan Stabilization Fund (see S. 124), S145 [24JA]

———require that prescription drug plans or Medicare Advantage-Prescription Drug plans with initial coverage limits obtain signed certification prior to enrolling benficiaries (see S. 2026), S12949 [16NO]

———require the negotiation and disclosure of the lowest possible prices for prescription drugs and permit beneficiaries to import prescription drugs from Canada (see H.R. 563), H351 [2FE]

Medicare/Medicaid: assist pharmacies in facilitating enrollment of dual eligible populations under the prescription drug benefit (see S. 2173), S14317 [21DE]

———eliminate coverage of drugs when used for treatment of erectile dysfunction (see H.R. 3543), H7558 [28JY]

———ensure that pharmacies receiving reimbursements fill all valid prescriptions without unnecessary delay or interference (see S. 778), S3555 [13AP]

———improve implementation of the Medicare prescription drug benefit for individuals who are both Medicare and Medicaid beneficiaries (see S. 1822), S11130 [5OC]

———prohibit coverage of sex-enhancing drugs for individuals convicted of a sex offense (see H.R. 2626), H4072 [25MY]

Members of Congress: ensure that prescription drug coverage for Members is not better than coverage for Medicare beneficiaries (see S. 143), S145 [24JA]

Mental health: protect children and their parents from being coerced into administering psychotropic medication in order to attend school (see H.R. 1790), H2471 [21AP]

National Alcohol and Drug Addiction Recovery Month: support goals and ideals (see H. Con. Res. 249), H8341 [22SE]

National Drug Court Month: designate (see S. Res. 136), S5071 [12MY]

———establish (see H. Res. 246), H2648 [27AP]

National Methamphetamine Prevention Week: establish (see S. Res. 313), S12839 [15NO] (see H. Res. 556), H10502 [16NO]

National Police Athletic League Youth Enrichment Act: revise and extend (see H.R. 4005), H8733 [6OC]

National security: prepare and strengthen biodefenses against deliberate, accidental, and natural outbreaks of illness (see S. 1873), S11422 [17OC]

National Vaccine Injury Compensation Program: amend (see H.R. 1297), H1507 [15MR]

Office of National Drug Control Policy: reauthorize (see H.R. 2829), H4354 [9JN]

———reauthorize and establish minimum drug testing standards for major professional sports leagues (see H.R. 2565), H3892 [24MY]

Patents: provide for compulsory licensing of certain patented inventions relative to health care emergencies (see H.R. 4102), H9042 [20OC] (see H.R. 4131), H9102 [25OC]

Pharmaceuticals: establish therapeutic equivalence requirements for generic drugs (see H.R. 2299), H3198 [11MY]

———impact of illegal importation of prescription drugs on regulatory protections afforded consumers (see H. Con. Res. 75), H796 [17FE]

———importation of prescription drugs (see S. 334), S1198 [9FE] (see H.R. 328), H194 [25JA] (see H.R. 700), H521 [9FE]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (see H.R. 578), H351 [2FE]

———standardize certification of Internet pharmacies and prohibit certain advertising by, and use of certain bank instruments for purchases from, illegal Internet pharmacies (see H.R. 1808), H2471 [21AP]

Public Health Service Act: increase affordability of inpatient drugs for Medicaid and safety net hospitals (see S. 1840), S11212 [6OC] (see H.R. 3547), H7558 [28JY]

Red Ribbon Week: support goals (see S. Res. 277), S11477 [18OC] (see H. Res. 485), H8734 [6OC]

Research: expand the clinical trials drug data bank (see S. 470), S1794 [28FE]

———provide incentives to companies to invest in research and development of antibiotic drugs, antivirals, diagnostic tests, and vaccines that may be used to identify, treat, or prevent an infectious disease (see H.R. 3154), H5600 [30JN]

Senior citizens: modify the eligibility criteria for supplemental foods provided under the Commodity Supplemental Food Program (see H.R. 782), H583 [10FE]

Social Security: delay implementation of voluntary prescription drug benefit program, extend Medicare prescription drug discount card and transitional assistance programs, and Medicaid coverage of prescription drugs (see H.R. 1382), H1692 [17MR]

Sports: establish minimum drug testing standards for major professional sports leagues (see S. 1114), S5851 [24MY] (see S. 1960), S12353 [3NO]

———establish standards for the testing of prohibited substances and methods for certain professional sports associations (see H.R. 2516), H3694 [19MY]

———provide for integrity and accountability in professional sports by strengthening testing for performance-enhancing drugs (see S. 1334), S7614 [29JN]

States: establish an electronic controlled substances monitoring program in each State (see S. 518), S2004 [3MR]

———provide with resources needed to rid our schools of performance-enhancing drug use (see S. 1974), S12526 [8NO]

Tariff: aspirin (see S. 1450), S8664 [21JY] (see H.R. 2433), H3555 [18MY]

———chloral (see H.R. 1725), H2393 [20AP]

———ezetimibe (see H.R. 2079), H2976 [4MY]

Taxation: add meningococcal vaccines to the list of taxable vaccines for purposes of the Vaccine Injury Compensation Trust Fund (see S. 1008), S5070 [12MY]

———allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (see H.R. 218), H78 [4JA]

———allow designation of income tax refunds for use in NIH biomedical research programs (see H.R. 370), H233 [26JA]

———allow new investment in, or mergers of biomedical research corporations without limiting tax benefits of net operating losses (see S. 1893), S11559 [19OC] (see H.R. 4082), H8985 [19OC]

———deny deductions for direct-to-consumer advertisements of prescription drugs (see H.R. 575), H351 [2FE]

———impose an excise tax on the termination of retiree prescription drug coverage (see H.R. 462), H284 [1FE]

———repeal the medicine and drugs limitation on the deduction for medical care (see S. 1514), S9158 [27JY] (see H.R. 3428), H6649 [26JY]

———treatment of foods and supplements for dietary use, and medical foods as medical expenses (see H.R. 2486), H3693 [19MY]

Terrorism: encourage more vigorous investigation and prosecution of drug crimes committed to provide material support to terrorist organizations (see H.R. 2593), H3893 [24MY]

———prohibit narco-terrorists from aiding and supporting terrorists and terrorist organizations (see S. 1642), S9833 [8SE]

———provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack (see S. 975), S4547 [28AP]

Treaties and agreements: avoid inclusion in future free trade agreements provisions that would restrict access of U.S. consumers to imported prescription drugs (see S. 1551), S9285 [28JY] (see H.R. 3583), H7559 [28JY]

U.S. Anti-Doping Agency: designate (see S. 529), S2004 [3MR]

Veterans: expand and enhance health care, mental health, transition, and disability benefits (see S. 13), S142 [24JA]

Factsheets

Rescind Advanced Technology Program Funding and Reallocate to NOAA, Community Oriented Policing, and State and Local Law Enforcement Assistance: Minnesota Factsheet, S9906 [12SE]

———Ohio Factsheet, S9904 [12SE]

———Virginia Factsheet, S9906 [12SE]

Trade Agreement Impediments to Availability of Patented and Generic Drugs in Developing Countries, S1499 [16FE]

Will Lower Drug Prices Jeopardize Drug Research? Donald Light and Joel Lexchin, American Journal of Bioethics, H5523-H5525 [30JN]

Letters

Colombia demobilization of foreign terrorist organizations: Eric L. Olson, Amnesty International (organization), H5975 [19JY]

———Jose M. Vivanco, Human Rights Watch (organization), H5974 [19JY]

Compulsory licensing of the influenza medication, Tamiflu: Representatives Kucinich, Sanders, and Berry, E2374 [16NO]

Gang Deterrence and Community Protection Act: Casey L. Perry, National Troopers Coalition, H3127 [11MY]

———Chuck Canterbury, Fraternal Order of Police, H3127 [11MY]

———Felipe A. Ortiz, National Latino Peace Officers Association, H3128 [11MY]

———Greg Nojeim and Jesselyn McCurdy, ACLU, H3129 [11MY]

———James J. Fotis, Law Enforcement Alliance of America, H3127 [11MY]

———Janet Murguia, National Council of La Raza, H3128 [11MY]

———Michael J. Bouchard and James A. Karnes, Major County Sheriff's Association, H3126 [11MY]

———Nicholas DiMarzio, U.S. Conference of Catholic Bishops and Larry Snyder, Catholic Charities USA (organization), H3129 [11MY]

———Roy L. Burns, Association for Los Angeles Deputy Sheriffs, Inc., H3126 [11MY]

———several business organizations, H3128 [11MY]

———Thomas N. Faust, National Sheriffs' Association, H3127 [11MY]

———Wesley D. McBride, California Gang Investigators Association, H3126 [11MY]

———William J. Johnson, National Association of Police Organizations, Inc., H3127 [11MY]

Justice Assistance Grant Program funding: Bob Bushman, Minnesota Police and Peace Officers Association, S9785 [8SE]

———Gene R. Voegtlin, International Association of Chiefs of Police, S9785 [8SE]

———James D. Franklin, Minnesota Sheriffs Association, S9785 [8SE]

———National Association of Police Officers, S9785 [8SE]

———Thomas N. Faust, National Sheriffs' Association, S12901, S12921 [16NO]

Liability protection to manufacturers of pandemic vaccines: Erwin Chemerinsky, S14247 [21DE], E2650 [22DE]

Medicaid Health Plan Rebate Act: Thomas Johnson, Medicaid Health Plans of America (organization), S9508 [29JY]

Negotiation of fair prices for Medicare prescription drugs: David P. Sloane, AARP, S12283 [2NO]

Pediatric vaccine manufacturer liability protection: Representative Burton, H6983 [28JY]

Prosecution of physicians for prescribing certain controlled substances for pain relief or management: National Association of Attorneys General, E691 [19AP]

Require manufacturers of dietary supplements to submit reports on certain serious adverse events before allowing sale on military installations: Bruce Silverglade and Ilene R. Heller, Center for Science in the Public Interest, S8637 [21JY]

———Debbie Riggins, S8636 [21JY]

———Janell Mayo Duncan, Consumers Union, S8637 [21JY]

———Kevin S. Riggins, S8636 [21JY]

———Michelle Skinlo, S8636 [21JY]

———Philip Shettle, American Osteopathic Association, S8637 [21JY]

Tribute to Centers for Medicare & Medicaid Services for demonstration project to assess quality of care of cancer patients undergoing chemotherapy: Representative Barton, Committee on Energy and Commerce (House), E2115 [18OC]

———Representative Thomas, Committee on Ways and Means (House), E2115 [18OC]

Lists

Amendments to H.R. 1279, Gang Deterrence and Community Protection Act, made not in order by the Committee on Rules (House), H3129 [11MY]

Committee on Government Reform (House) Subcommittee on Criminal Justice, Drug Policy and Human Resources methamphetamine hearings since 2001, H10371 [16NO]

Messages

Interdiction of Aircraft Engaged in Illicit Drug Trafficking: President Bush, S1930 [2MR], H917 [2MR]

National Emergency Relative to Narcotics Traffickers in Colombia: President Bush, S11557 [19OC], H8951 [19OC]

Motions

Crime: reduce violent gang crime and protect law-abiding citizens and communities from violent criminals (H.R. 1279), H3159 [11MY]

Press releases

Adoption of ``Law of Justice and Peace'' in Colombia: Inter-American Commission on Human Rights, H5974 [19JY]

Remarks in House

Advertising: prohibit as indecent the broadcasting of any advertisement for a medication for the treatment of erectile dysfunction (H.R. 1420), E498 [17MR]

Afghanistan: eradicate poppy plant, H4406 [14JN]

———reduce drug trafficking to eliminate financial support that traffickers provide to terrorist organizations, H5285 [28JN]

Africa: develop plan to protect blood supply from infectious diseases, H5286 [28JN]

———use of West Africa as hub for drug trade to Europe and North America, E1729 [29JY]

Andean Free Trade Agreement (AFTA): potential impact on illegal drug imports into the U.S., H9073 [25OC]

Asthma Awareness Day: observance, H2746 [3MY]

Braga, Damian: Pocono Mountains Chamber of Commerce Chairman's Business Award recipient, E2246 [3NO]

Brazil: compulsory licensing of AIDS drug in order to produce generic version, E1389 [28JN], E1435 [1JY]

Buffalo, NY: tribute to Buffalo Drug Treatment Court, E921 [10MY]

Burlington, VT: anniversary of Howard Center for Human Services, E2 [4JA]

Business and industry: provide incentives for investment in research and development of new medicines and to enhance access to new medicines (H.R. 417), E149 [2FE]

Centers for Medicare & Medicaid Services: tribute for demonstration project to assess quality of care of cancer patients undergoing chemotherapy (H. Res. 261), H8683-H8685 [6OC], E1562 [21JY], E1732 [29JY]

Children and youth: abuses in pediatric HIV drug trials, E37 [6JA]

Coast Guard: role in disaster relief and security efforts, H8233-H8237 [21SE]

Colombia: right-wing paramilitary forces demobilization funding, H5973, H5979 [19JY], H9646 [4NO]

Comprehensive AIDS Resources Emergency Act: grant extension to States for expiring, unexpended funding, H5151, H5152 [24JN]

Congress: relationship with special interest groups, H6438 [26JY]

Consumers: discrepancy in prescription drug prices between U.S. and foreign countries, H606 [15FE], H1328 [10MR], H1754 [5AP], H3406 [17MY], H4159 [7JN], H4373 [13JN], H4784 [20JN], H4861 [21JN], H5219 [27JN], E1159, E1162 [8JN]

———promote fairer prescription drug pricing through Internet sites supported by public-private partnerships, H11658 [15DE]

Controlled Substances Act: exclude industrial hemp from the definition of marijuana (H.R. 3037), E1313 [22JN]

Council of Economic Advisers: prohibit funding to produce a President's economic report regarding a certain average cost of developing and introducing a new prescription drug to the market, H5522-H5526 [30JN]

Courts: application of mandatory minimum sentences to certain gang crime, H3154-H3157 [11MY]

———permit civil actions alleging that products claiming to assist in weight loss caused heart disease or other complications, H8935, H8936 [19OC]

———prohibit punitive damages against manufacturers of medical products that comply with FDA standards, H6862-H6867 [27JY], H6986, H6987, H6996, H6999, H7000 [28JY]

———treatment of class action lawsuits involving the arthritis drug Vioxx, H753 [17FE], H6110 [20JY]

Crime: increase sentencing for violent crimes or drug trafficking offenses committed by illegal aliens, H3124, H3150-H3152 [11MY]

———provide an increased penalty for endangering a child while illegally manufacturing a controlled substance (H.R. 1616), H4194 [8JN]

———provide grants to States to combat methamphetamine abuse, H4384-H4391 [13JN], H4411 [14JN], H10068, H10069, H10073 [9NO]

———provide grants to States to combat methamphetamine abuse (H.R. 313), H3681 [19MY]

———reduce criminal gang activities (H.R. 970), H1328 [10MR]

———reduce foreign shipments of pseudoephedrine used in the production of methamphetamine, H4437 [14JN]

———reduce violent gang crime and protect law-abiding citizens and communities from violent criminals (H.R. 1279), H3028 [5MY], H3063 [10MY], H3134-H3161, H3164 [11MY], H8404 [28SE], E949, E953 [12MY], E970, E971 [13MY], E1006 [18MY], E1269 [17JN]

———reduce violent gang crime and protect law-abiding citizens and communities from violent criminals (H.R. 1279), amendment process, H3028 [5MY]

———reduce violent gang crime and protect law-abiding citizens and communities from violent criminals (H.R. 1279), consideration (H. Res. 268), H3120-H3133 [11MY]

———respond to the illegal production, distribution, and use of methamphetamines, H3762-H3765 [23MY], H7839 [13SE], H9074 [25OC], H11509, H11510, H11517, H11519, H11520, H11522, H11531, H11535, H11539 [14DE], E2549 [15DE]

———respond to the illegal production, distribution, and use of methamphetamines (H.R. 314), H3681 [19MY]

———respond to the illegal production, distribution, and use of methamphetamines (H.R. 3889), H10368-H10377 [16NO]

Democratic Party: national agenda, H2533 [26AP]

Dept. of HHS: AIDS Drug Assistance Program funding, E1351 [24JN]

———bar-code medication technology funding, H5072, H5073 [23JN]

———ensure prescription drug clinical trials required to be listed in a public database are listed before a drug is approved for market, H4263, H4264 [8JN]

———give grant preference to States that require schools to allow students to self-administer medication for asthma or anaphylaxis, H2746 [3MY]

———prohibit use of funding to implement a universal mental health screening program, H5145, H5146 [24JN]

———require report on the correlation between a perpetrator's drug and alcohol abuse and reported incidence of domestic violence, H8473, H8474 [28SE]

———Strategic National Stockpile funding for influenza vaccine production and antiviral treatments, H5033 [23JN]

Dept. of Homeland Security: Advanced Technology Northern Border Security Pilot Program implementation, H3491 [18MY]

———Office of Counternarcotics Enforcement funding, H3368, H3369 [17MY], H3486, H3503-H3505 [18MY]

Dept. of HUD: Community Development Block Grant Program section 108 loan guarantee program funding through reductions in Office of National Drug Control Policy funding, H5383, H5444 [29JN]

Dept. of Justice: authorize export of certain narcotic drugs and nonnarcotic controlled substances to a country for subsequent export from that country to another country, if certain conditions are met (S. 1395), H6671-H6673 [27JY]

———Community Oriented Policing Services (COPS) Program funding through reductions in FBI and DEA funding, H4456, H4457 [14JN]

———Community Oriented Policing Services (COPS) Program funding through reductions in NSF funding, H4496-H4498 [15JN], E1255 [17JN]

———Community Oriented Policing Services (COPS) Program funding to combat methamphetamine abuse, H4495 [15JN]

———DEA and Community Oriented Policing Services (COPS) Program funding through reductions in Bureau of the Census funding, H4458, H4459 [14JN]

———Justice Assistance Grant Program funding, H4384-H4391 [13JN], H4442-H4445 [14JN], E2334 [10NO]

———prohibit funding to prevent implementation of State laws relative to the use of marijuana for medicinal purposes, H4519-H4524 [15JN], E1312 [22JN]

Dept. of State: Andean Counterdrug Initiative funding for Colombia, H5307-H5317 [28JN]

———Andean Counterdrug Initiative funding for Peru, H5291, H5292 [28JN]

———Bureau for International Narcotics and Law Enforcement Affairs funding to purchase or lease a refueling vessel to support U.S. drug interdiction efforts in the Eastern Pacific maritime transit zone, H8046 [15SE]

———Global HIV/AIDS Initiative funding, H5306, H5307 [28JN]

———maritime refueling support vessel for drug interdiction efforts in Eastern Pacific transit zone funding, H6049 [19JY]

———provide assistance to Mexico to prevent the production of methamphetamine and prevent diversion of methamphetamine precursors for illicit use, H6046, H6047, H6048 [19JY]

———require certification that certain countries importing and exporting methamphetamine precursors are cooperating with U.S. law enforcement to prevent diversion of the chemicals for illicit use, H6044-H6046 [19JY], E1539 [20JY]

———require report identifying all pending requests for extradition of Afghan drug traffickers, including status and response to such requests by Afghanistan, H6047, H6048 [19JY]

———shift Andean Counterdrug Initiative funding from fumigation to alternative farming development programs in Colombia, H5287 [28JN], H5979 [19JY], H6167 [20JY]

———transfer marine patrol aircraft to Colombia for drug interdiction operations in coastal waters, H6042-H6044 [19JY]

Dept. of Veterans Affairs: pain management research programs funding, H4099 [26MY]

Diseases: anniversary of development of Salk polio vaccine, E622 [12AP]

———anniversary of development of Salk polio vaccine (H. Res. 208), H2171-H2174 [20AP]

———authorize assistance to combat HIV/AIDS pandemic in sub-Saharan Africa, H5286, H5295, H5296 [28JN], H6130 [20JY]

———ensure an adequate supply of influenza vaccine and syringes, E2358 [15NO]

———expand assistance to countries seriously affected by HIV/AIDS, malaria, and tuberculosis, H9311, H9312 [27OC], E2238 [1NO]

———improve preparation for an influenza pandemic, including an avian influenza pandemic, H5714 [12JY], H9073 [25OC], H9280, H9332 [27OC], H9437, H9440, H9441, H9448, H9451 [1NO], H9699, H9939-H9941 [7NO], H10148 [10NO], H11185 [7DE], H12264 [18DE], E2303 [8NO]

———improve preparation for an influenza pandemic, including an avian influenza pandemic (H.R. 3369), H8800 [7OC]

———improve preparation for an influenza pandemic, including an avian influenza pandemic (H.R. 4245), H9932, H9939 [7NO]

Dominican Republic-Central America Free Trade Agreement (DR-CAFTA): impact on the ability of developing nations to acquire generic medications, H6926 [27JY]

Drug abuse: national drug control policy, H3414-H3421 [17MY]

Drunken driving: allow use of Alcohol-Impaired Driving Countermeasures grant funding for Driving While Intoxicated Courts, H1308 [10MR]

FDA: delay approval of genetically engineered fish, H4265 [8JN]

———drug and medical device approval process, H815 [1MR]

———ensure autonomy and eliminate conflicts-of-interest relative to drug company fees and advisory panels, H4245-H4247 [8JN]

———improve postmarket drug safety, H4206, H4219, H4221, H4242, H4244 [8JN]

———promote competition and drug safety through increased research, E903 [5MY]

———withdraw approved application for the drug known as RU-486 and review process by which the FDA approved such drug, H6209 [21JY]

———withdraw approved application for the drug known as RU-486 and review process by which the FDA approved such drug (H.R. 1079), H1332 [10MR], E357 [3MR]

Federal aid programs: drug treatment and prevention programs funding, E1065 [23MY]

———prohibit Federal payment or reimbursement for drugs prescribed for the treatment of sexual or erectile dysfunction, H5126-H5128 [24JN]

———prohibit Federal payment or reimbursement for drugs prescribed to sex offenders for the treatment of sexual or erectile dysfunction, H4988, H5037 [23JN]

Federal Food, Drug, and Cosmetic Act: amend relative to dietary supplements (H.R. 3156), E1441 [1JY]

———enhance criminal penalties for certain violations involving concealment of evidence of a serious adverse drug experience (H.R. 870), E252 [16FE]

———establish recall authority for drugs and increase criminal penalties for sale or trade of knowingly adulterated or misbranded prescription drugs (H.R. 2345), E950 [12MY]

Foreign aid: public health and preventable illness initiatives funding, H1646 [17MR]

Foreign countries: remove all embargoes on food, medicine, and medical supplies (H.R. 1527), E575 [7AP]

Foreign trade: provide for importation of pharmaceutical products under a compulsory license as provided for under the World Trade Organization (H.R. 4392), E2424 [18NO]

Georgetown, DE: tribute to La Red Health Center, E824 [28AP]

Global Fund To Fight AIDS, Tuberculosis, and Malaria (organization): funding, H5303 [28JN]

Government regulations: eliminate safe-harbor exception for certain packaged pseudoephedrine products used in manufacturing methamphetamine (H.R. 1446), H2784 [3MY], H3681 [19MY]

———establish certain restrictions on drugs containing isotretinoin, including the drug marketed as Accutane, H2950 [4MY], H4477 [14JN]

———transfer ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances (H.R. 3955), H10135 [9NO]

Haiti: prohibit funding for transfer of certain excess Government property, H5340, H5341 [28JN], H9669 [4NO]

Health: conduct vaccine awareness campaign, ensure sufficient vaccine supply, prepare for pandemic or epidemic, and encourage vaccine production capacity relative to influenza (H.R. 813), H1900 [13AP]

———ensure sufficient vaccine supply, H3586 [19MY]

———improve accessibility to immunizations against vaccine-preventable diseases, study Medicare and Medicaid influenza immunization usage, and amend Federal employee immunization services (H.R. 3598), H6939 [28JY], E1662 [29JY]

———improve patient safety and reduce incidence of medical errors, H6999 [28JY]

———improve patient safety and reduce incidence of medical errors (H.R. 3205), H6208 [21JY]

———improve patient safety and reduce incidence of medical errors (S. 544), H6673-H6679 [27JY], H6997 [28JY]

———integrate medical and mental health services to coordinate more effective diagnosis and treatment, H2399 [21AP], H9943-H9945 [7NO]

———link between child vaccinations containing mercury and autism, H481 [9FE], H5074 [23JN], H9451 [1NO]

———national policy to provide health care and reform insurance procedures, H174 [25JA]

———provide assistance to combat HIV/AIDS, H10518 [17NO]

———provide liability protection to manufacturers of pandemic vaccines, H12054 [17DE], H12227-H12230 [18DE], H13181 [22DE], E2650 [22DE]

———provide residential substance abuse treatment programs to those who pass a regularly administered drug-screening test and provide aftercare to prisoners formerly enrolled in such programs, H8473 [28SE]

———review expiration dates for prescription drugs, H4300 [9JN]

Health care professionals: clarify responsibilities of a pharmacy when a staff pharmacist refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions (H.R. 1652), E658 [15AP]

———establish electronic systems in each State for practitioner monitoring of the dispensing of certain controlled substances (H.R. 1132), H6681-H6686 [27JY], E691 [19AP], E1811 [8SE], E1989 [29SE]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (S. 45), H6679-H6681 [27JY]

———reform the medical malpractice system (H.R. 2657), H6408 [25JY]

House of Representatives: legislative priorities, H11331 [12DE]

Hurricanes: temporarily suspend laws that deny certain Federal benefits, grants, and licenses to victims of Hurricanse Katrina or Rita due to convictions for certain drug crimes (H.R. 4169), E2203 [27OC]

———temporarily suspend laws that deny certain Federal benefits, grants, and licenses to victims of Hurricanse Katrina or Rita due to convictions for certain drug crimes (H.R. 4213), E2258 [3NO]

Immigration: enhance penalties for crimes related to document fraud and drug trafficking, H11973-H11975 [16DE]

———improve border security, H7599 [29JY], H9418-H9424 [28OC], H10366 [16NO]

Insurance: provide nondiscriminatory coverage of substance abuse treatment services under private group and individual health coverage (H.R. 1258), H8218, H8219, H8220 [21SE]

Lakeville, MN: tribute to Lakeville High School Challenge to Change Program, H2885 [4MY]

Law enforcement: ensure adequate funding is provided for certain high intensity drug trafficking areas (H.R. 812), H604 [15FE]

———High Intensity Drug Trafficking Area Program and Justice Assistance Grant Program funding, H3762-H3765 [23MY]

———increase evidentiary standard required to convict a person for a drug offense and require screening of law enforcement officers or others acting under color of law participating in drug task forces, H4589-H4592 [16JN]

———prohibit prosecution of physicians for prescribing certain controlled substances for pain relief or management, E691 [19AP]

———provide for research on and standards for remediation of closed methamphetamine production laboratories (H.R. 798), H11462-H11467 [13DE], E2534 [14DE]

Marijuana: efforts of certain organizations to legalize marijuana, E78 [25JA], E101 [26JA]

Medicaid: anniversary, E1742 [29JY]

———funding, H1560 [16MR], H1671 [17MR], H10045 [9NO], H10150 [10NO]

———GAO study on pharmacy reimbursements for enrollees' prescriptions, H10631 [17NO]

———reform, H10008 [8NO], H10118, H10119, H10123 [9NO]

———require drug utilization review programs to deny coverage of erectile dysfunction drugs for individuals registered (or required to be registered) as sex offenders (H.R. 2648), H5037 [23JN]

———require States to pay dispensing fees to pharmacies for prescriptions, H10639 [17NO]

Medicare: cost estimates for prescription drug benefit program, H526 [10FE], H699 [16FE], H757 [17FE], H3247 [12MY]

———cost of prescription drug benefit coverage implementation, H11275 [8DE], H11510 [14DE]

———coverage of outpatient prescription drugs, H418 [9FE], H1344 [10MR], H6210 [21JY], H8394 [28SE], H8832 [17OC], H8902-H8907 [18OC], H9090 [25OC]

———deliver a meaningful benefit and lower prescription drug prices (H.R. 752), E1940 [22SE]

———ensure that prescription drug benefits have no impact on benefits under other Federal programs (H.R. 2746), E1152 [7JN]

———extend implementation of prescription drug program, H11331 [12DE]

———extend initial enrollment period for prescription drug benefits, waive penalties for late enrollment, and provide other additional beneficiary protections (H.R. 4410), H11189 [7DE]

———improve coordination of prescription drug coverage under retiree plans and State pharmaceutical assistance programs with Medicare drug benefits (H.R. 152), E22 [4JA]

———improve coordination of prescription drug coverage under State pharmaceutical assistance programs with Medicare drug benefits (H.R. 1572), E629 [12AP]

———improve implementation of the Medicare prescription drug benefit, H8651 [6OC]

———permit the Dept. of HHS to enter into direct negotiations to promote the best prices for beneficiaries, H11275 [8DE], H11331 [12DE], H12055 [17DE], E2445 [6DE]

———permit the Dept. of HHS to enter into direct negotiations to promote the best prices for beneficiaries (H.R. 376), H3758 [23MY], H9934 [7NO]

———prescription drug benefit coverage, H9968 [8NO], H10149 [10NO], H10164, H10166, H10167, H10190, H10193, H10195, H10208-H10214 [15NO], H10231, H10232, H10233 [16NO], H11115, H11116, H11184 [7DE], H11508, H11509, H11510 [14DE], H11659 [15DE], E2394 [17NO]

———prescription drug discount card program implementation, H3046 [5MY]

———provide additional beneficiary protections (H.R. 2487), E1046 [20MY]

———provide extended and additional protection to beneficiaries enrolled in prescription drug benefit plans (H.R. 3861), H11511, H11512 [14DE], H12055 [17DE], E1932, E1940 [22SE]

Medicare Prescription Drug, Improvement, and Modernization Act: implementation and funding, H1757-H1763 [5AP]

Medicare/Medicaid: funding, H10007, H10008 [8NO]

Mental health: protect children and their parents from being coerced into administering psychotropic medication in order to attend school (H.R. 1790), H10185-H10187 [15NO], E2379, E2380 [17NO]

Mexico: international narcotics control and law enforcement funding, H5292, H5296 [28JN]

Morality and ethics: national objectives priority assignments, H7839-H7843 [13SE]

Motor vehicles: improve safety and enforcement relative to operation while under the influence of, or having used, drugs, H1048 [9MR]

National Addiction Counselors' Day: observance, E1895 [20SE]

National Alcohol and Drug Addiction Recovery Month: observance, H8218, H8219 [21SE], E1700 [29JY], E1832 [13SE], E1903 [20SE], E1908 [21SE], E1978 [28SE]

National Institute on Drug Abuse: address relationship between alcohol and drug addiction and the spread of HIV/AIDS, E2452 [6DE], E2463 [7DE]

Office of National Drug Control Policy: High Intensity Drug Trafficking Areas Program funding, H5383, H5458, H5459 [29JN]

———National Youth and Anti-Drug Media Campaign funding through reductions in GSA Federal Buildings Fund funding, H5459-H5461 [29JN]

———reauthorize and establish minimum drug testing standards for major professional sports leagues (H.R. 2565), H9074 [25OC]

Pfizer, Inc.: tribute to humanitarian support for victims of the Indian Ocean tsunami, E298 [18FE]

Pharmaceuticals: development of electronic prescribing systems to improve patient safety and quality of care for patients, H722 [17FE]

———establish uniform standards for restocking of unused drugs, H2652 [28AP]

———impact of industry lobbyists, H2534 [26AP]

———importation of prescription drugs, H418 [9FE], H4220 [8JN], H4861 [21JN], H6654 [27JY]

———importation of prescription drugs (H.R. 328), H1945, H1947 [13AP], H3289 [16MY], H4373 [13JN], H9934 [7NO]

———pediatric vaccine manufacturer liability protection, H6867, H6868 [27JY], H6983, H7000 [28JY]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (H.R. 578), E144 [2FE]

———require pharmacists manage and monitor medications for patients with chronic illness, H8737 [7OC]

Red Ribbon Week: support goals (H. Res. 485), H9058, H9059, H9074 [25OC]

Research: provide incentives to companies to invest in research and development of antibiotic drugs, antivirals, diagnostic tests, and vaccines that may be used to identify, treat, or prevent an infectious disease, H9280 [27OC]

Richey, John W.: Good Neighbor Pharmacist of the Year award recipient, E2577 [17DE]

Senior citizens: modify the eligibility criteria for supplemental foods provided under the Commodity Supplemental Food Program (H.R. 782), E222 [10FE]

Taxation: allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (H.R. 218), E18 [4JA]

Terrorism: encourage more vigorous investigation and prosecution of drug crimes committed to provide material support to terrorist organizations, H6292-H6294 [21JY], H11538 [14DE]

———encourage more vigorous investigation and prosecution of drug crimes committed to provide material support to terrorist organizations (H.R. 2593), E1073 [24MY]

Treaties and agreements: impact of trade agreements on the pharmaceutical industry, H4312 [9JN]

U.N.: Codex Alimentarius Commission recommendation on dietary supplements standards, E1455 [11JY]

Veterans: health care funding, H512-H518 [9FE], H604, H621-H626 [15FE], H1572 [16MR]

World AIDS Day: observance, E2452 [6DE]

Remarks in Senate

Advertising: provide discounts to Medicaid and other Federal programs for the advertising costs of certain prescription drugs and ensure that these drugs are prescribed based on health needs rather than marketing (S. 1128), S6056, S6057 [26MY]

Anabolic Steroid Control Act: technical corrections (S. 893), S4162 [25AP]

Budget: allocation of funds, S12878 [16NO]

Camarena, Enrique (Kiki): tribute (S. Res. 73), S2274 [8MR], S2585 [11MR]

Consumers: discrepancy in prescription drug prices between U.S. and foreign countries, S8397-S8399 [18JY]

Contraceptives: require equitable coverage of drugs, devices, and services under health insurance plans (S. 1214), S6316-S6318 [9JN]

Crime: allow for the prosecution of members of criminal street gangs (S. 1322), S7526-S7530 [28JN]

———provide grants to States to combat methamphetamine abuse, S10025 [14SE], S12814, S12817 [15NO]

———provide grants to States to combat methamphetamine abuse (S. 430), S1649 [17FE]

———reduce criminal gang activities (S. 155), S474, S482 [25JA]

———respond to the illegal production, distribution, and use of methamphetamines, S9873, S9874 [9SE], S9972 [13SE], S9997-S9999 [14SE], S13517, S13521 [14DE], S13712 [16DE], S14234 [21DE]

———respond to the illegal production, distribution, and use of methamphetamines (S. 103), S6473 [14JN], S7608 [29JN], S8547 [20JY], S12520 [8NO]

Davidson, Jay: Johnson Institute America Honors Recovery Award recipient, S10591 [28SE]

Democratic Party: national agenda, S110 [24JA]

Dept. of Education: Safe and Drug-Free Schools and Communities State Grant Program funding, S11806, S11807 [25OC]

Dept. of HHS: promulgate regulations for the reimportation of prescription drugs (S. 109), S278 [24JA], S1156 [9FE]

———revise minimum allotments under the Projects for Assistance in Transition From Homelessness (PATH) Program (S. 319), S1134 [8FE]

Dept. of Justice: authorize export of certain narcotic drugs and nonnarcotic controlled substances to a country for subsequent export from that country to another country, if certain conditions are met (S. 1395), S8244 [13JY], S8292 [14JY]

———Community Oriented Policing Services (COPS) Program methamphetamine enforcement and clean up program funding through closing of certain tax loopholes, S2938, S2939 [17MR]

———establish a National Methamphetamine Information Clearinghouse (S. 2046), S13173 [17NO]

———Justice Assistance Grant Program funding, S9785 [8SE], S9972 [13SE], S12879, S12899-S12901, S12921, S12922 [16NO], S13151 [17NO], S13350 [18NO]

———juvenile justice funding, S2953 [17MR]

Dept. of Veterans Affairs: permit Medicare-eligible veterans to receive an outpatient medication benefit (S. 614), S2648 [14MR]

Developing countries: accelerate efforts to develop vaccines for diseases primarily affecting developing countries (S. 1698), S10039, S10043 [14SE]

———trade agreement impediments to availability of patented and generic drugs in developing countries, S1498 [16FE]

Dietary supplements: require manufacturers to submit reports on certain serious adverse events before allowing sale on military installations, S8635-S8638 [21JY]

———withhold funding from stores on military installations that sell dietary supplements containing stimulants in cases that the manufacturer does not report associated serious adverse events, S11096-S11099 [5OC]

Diseases: anniversary of development of Salk polio vaccine, S3442, S3448, S3479 [12AP]

———anniversary of development of Salk polio vaccine (S. Res. 101), S3338 [6AP]

———avian flu prevention and response funding, S4087, S4088 [21AP]

———improve access to HIV/AIDS-related treatments and services in developing countries, S381 [25JA]

———improve and secure an adequate supply of influenza vaccine (S. 1828), S11220-S11222 [6OC]

———improve preparation for an influenza pandemic, including an avian influenza pandemic, S10529-S10531 [28SE], S10652-S10656, S10685-S10693, S10701, S10714 [29SE], S11818 [25OC], S11886-S11889 [26OC], S11958-S11969, S11972, S11978-S11980 [27OC], S12079, S12090, S12096 [1NO], S12805 [15NO], S13605 [15DE], S13948, S13960 [17DE], S14235, S14286, S14288, S14293 [21DE]

———improve preparation for an influenza pandemic, including an avian influenza pandemic (S. 1821), S11132-S11139 [5OC], S11451, S11468 [18OC]

———improve preparation for an influenza pandemic, including an avian influenza pandemic (S. 969), S4581 [28AP], S8447 [19JY], S10626-S10629 [28SE]

———promote initiatives to develop an HIV vaccine (S. Res. 42), S1063 [7FE]

———provide assistance to countries to combat malaria, S8475 [19JY]

———provide assistance to countries to combat tuberculosis, malaria, and other infectious diseases (S. 950), S4568 [28AP]

Education: school methamphetamine education programs funding, S9907 [12SE]

FDA: condemn delay of decision on the approval of over-the-counter emergency contraceptives, S10249 [21SE]

———ensure autonomy and eliminate conflicts-of-interest relative to drug company fees and advisory panels, S10217 [20SE]

———improve ability to ensure drug safety (S. 930), S4426, S4427 [27AP], S13095 [17NO]

———Inspector General investigation funding relative to delay of decision on the approval of over-the-counter emergency contraceptives, S11907 [26OC]

———withdraw approved application for the drug known as RU-486 and review process by which the FDA approved such drug (S. 511), S2020 [3MR]

Federal aid programs: prohibit Federal payment or reimbursement for drugs prescribed for the treatment of sexual or erectile dysfunction (S. 1113), S5854 [24MY]

Federal Food, Drug, and Cosmetic Act: establish requirements to allow sale of prescription drugs over the Internet (S. 399), S1531, S1534 [16FE]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (S. 742), S3407 [11AP]

Global Fund To Fight AIDS, Tuberculosis, and Malaria (organization): funding, S2938, S2947 [17MR]

———funding through reductions in Iraq Economic Support Fund funding, S8470, S8471 [19JY]

Government regulations: protect the public from unsafe importation of prescription drugs and from counterfeit prescription drugs, S5433 [18MY]

Health: conduct vaccine awareness campaign, ensure sufficient vaccine supply, prepare for pandemic or epidemic, and encourage vaccine production capacity relative to influenza (S. 375), S1415 [15FE]

———eliminate price cap applicable to purchase of influenza vaccines and establish a tax credit to encourage vaccine production capacity (S. 96), S261 [24JA]

———ensure vaccine awareness, sufficient vaccine supply, and vaccine production capacity, S3442 [12AP], S3610 [14AP]

———improve accessibility to and administration of immunizations against vaccine-preventable diseases, including influenza (S. 1527), S9292 [28JY]

———improve patient safety and reduce incidence of medical errors (S. 544), S8713, S8714 [21JY], S8741-S8744 [22JY], S9060 [27JY]

———include dehydroepiandrosterone as an anabolic steroid (S. 1137), S6030 [26MY]

———national policy to provide health care and reform insurance procedures (S. 16), S110, S111, S127, S183 [24JA]

———promote a culture of safety within the health care system through the establishment of a National Medical Error Disclosure and Compensation Program (S. 1784), S10599 [28SE]

———provide compensation for injuries resulting from smallpox countermeasures, provide protection against chemical or radiological agents, increase distribution of vaccines, and improve vaccine injury compensation, S1598 [17FE]

———provide liability protection to manufacturers of pandemic vaccines, S14142-S14146 [20DE], S14234-S14238, S14242-S14244, S14246, S14249 [21DE], S14424 [22DE]

———require notification by manufacturers before discontinuing production of a vaccine and develop a national vaccine stockpile (S. 226), S741 [1FE]

———safety of vaccines containing mercury and thimerosal, S11994 [27OC]

Health care facilities: provide for public disclosure of charges for certain hospital services and drugs (S. 1827), S11220 [6OC]

Health care professionals: clarify responsibilities of a pharmacy when a staff pharmacist refuses to fill a valid prescription for a drug on the basis of religious beliefs or moral convictions (S. 809), S3685 [14AP]

———educate concerning substance use disorders and addiction (S. 538), S2162 [7MR]

———establish electronic systems in each State for practitioner monitoring of the dispensing of certain controlled substances (H.R. 1132), S9584 [29JY]

———lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices (S. 45), S231 [24JA], S829 [1FE], S8501 [19JY]

Immigration: improve border security, S14228 [21DE]

India: provide assistance to combat HIV/AIDS (S. 674), S3055 [17MR]

Indian Health Service: Alcohol and Substance Abuse Program and Special Diabetes Program for Indians funding through reductions in Federal land acquisition funding, S7491 [28JN]

———Alcohol and Substance Abuse Program and Special Diabetes Program for Indians funding through reductions in federal land acquisition funding, S7495-S7497 [28JN]

Insurance: provide nondiscriminatory coverage of substance abuse treatment services under private group and individual health coverage (S. 803), S3680 [14AP]

Japan: urge honoring of commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals (S. Con. Res. 67), S13402 [18NO]

Law enforcement: High Intensity Drug Trafficking Area Program and Justice Assistance Grant Program funding, S6473 [14JN]

———prevent illegal importation of controlled substances (S. 400), S1531 [16FE]

———provide for research on and standards for remediation of closed methamphetamine production laboratories (S. 2019), S12954 [16NO]

Medicaid: anniversary (S. Con. Res. 49), S9542-S9544 [29JY]

———clarify treatment of prescription drug distributor service fees, S14205 [21DE]

———contain costs of prescription drug program, S2145 [7MR]

———eliminate increase in rebate for generic drugs, S12318, S12319 [3NO]

———ensure that rural remote pharmacies receive reimbursements for enrollees' prescriptions, S12325 [3NO]

———exclude discounts provided to mail order and nursing facility pharmacies from the determination of average manufacturer price, S12318 [3NO]

———exclude prompt-pay discounts from pharmacy reimbursement methodology, S12327 [3NO]

———extend prescription drug rebate program to enrollees of managed care organizations (S. 1585), S9507 [29JY]

———prevent a severe reduction in the Federal medical assistance percentage determined for a State and extend rebates for prescription drugs to enrollees in Medicaid managed care organizations, S12185-S12188 [2NO], S12307 [3NO]

———require States to pay dispensing fees to pharmacies for prescriptions, S12326 [3NO]

Medicare: continue Medicaid prescription drug coverage to dual-eligible beneficiaries for a certain period while allowing part D benefits to be implemented as scheduled, S11853-S11855, S11858 [26OC]

———continue Medicaid prescription drug coverage to dual-eligible beneficiaries for a certain period while allowing part D benefits to be implemented as scheduled (S. 566), S2270 [8MR], S13342 [18NO]

———coverage of outpatient prescription drugs, S2604 [14MR]

———deliver a meaningful benefit and lower prescription drug prices (S. 345), S1272, S1273 [10FE]

———deliver a meaningful benefit and lower prescription drug prices (S. 873), S4137 [21AP], S4157 [22AP], S10525 [27SE]

———improve coordination of prescription drug coverage under State pharmaceutical assistance programs with Medicare drug benefits (S. 764), S3487 [12AP]

———improve (S. 18), S111, S208-S210 [24JA]

———negotiate for lower prices for prescription drugs (S. 813), S3747 [15AP]

———permit negotiation of fair prices for, and allow the reimportation of, prescription drugs, S2821-S2825 [16MR], S2921, S2953 [17MR]

———permit negotiation of fair prices for, and allow the reimportation of, prescription drugs (S. 239), S745-S747 [1FE], S877 [2FE], S1152 [9FE], S1252, S1253 [10FE], S1321 [14FE], S1597 [17FE]

———prescription drug discount card program implementation, S132-S134 [24JA]

———prohibit the telemarketing of prescription drug and Advantage plans to beneficiaries (S. 1798), S10747 [29SE], S10793 [30SE]

———provide extended and additional protection to beneficiaries enrolled in prescription drug benefit plans, S13119, S13128, S13129 [17NO]

———provide extended and additional protection to beneficiaries enrolled in prescription drug benefit plans (S. 1841), S11231 [6OC], S12726 [14NO], S12826-S12828 [15NO]

———provide extended and additional protection to beneficiaries enrolled in prescription drug benefit plans (S. 1841), unanimous-consent request, S12828 [15NO]

———provide extended and additional protections to certain beneficiaries (S. 2168), S14329 [21DE]

———provide for negotiation of fair prices for prescription drugs, S12282-S12284 [2NO], S12324, S12325, S12346 [3NO]

———provide for negotiation of fair prices for prescription drugs (S. 123), S315 [24JA]

———provide for negotiation of fair prices for prescription drugs (S. 445), S1658 [17FE], S13342 [18NO]

———reform and provide prescription drug coverage, S16 [4JA]

———repeal Medicare Advantage Regional Plan Stabilization Fund (S. 124), S316 [24JA]

———require certification prior to beneficiary enrollment in a prescription drug plan, S12313 [3NO]

———require that prescription drug plans or Medicare Advantage-Prescription Drug plans with initial coverage limits obtain signed certification prior to enrolling benficiaries (S. 2026), S12958 [16NO]

Medicare/Medicaid: assist pharmacies in facilitating enrollment of dual eligible populations under the prescription drug benefit (S. 2173), S14334 [21DE]

———ensure that pharmacies receiving reimbursements fill all valid prescriptions without unnecessary delay or interference (S. 778), S3564 [13AP]

———improve implementation of the Medicare prescription drug benefit for individuals who are both Medicare and Medicaid beneficiaries, S12202-S12207 [2NO], S12309 [3NO]

———improve implementation of the Medicare prescription drug benefit for individuals who are both Medicare and Medicaid beneficiaries (S. 1822), S11139 [5OC], S11853-S11855 [26OC]

Mercer County, WV: tribute to Mercer County Drug Free Community Support Program, S12126 [1NO]

National Addiction Counselors' Day: observance, S10229 [20SE]

National Guard: counterdrug support activities funding, S11186, S11187 [6OC]

NIST: rescind Advanced Technology Program funding and reallocate to NOAA, community oriented policing, and State and local law enforcement assistance, S9903-S9907 [12SE], S10021-S10023 [14SE]

Office of National Drug Control Policy: High Intensity Drug Trafficking Areas Program funding, S2940, S2948, S2952 [17MR]

Office of the U.S. Trade Representatives: prevent negotiation of trade agreements that prevent the U.S. from changing patent laws to allow the importation of pharmaceutical product, S10077, S10078 [15SE]

Pharmaceuticals: importation of prescription drugs (S. 334), S1206 [9FE], S1253, S1256 [10FE], S10077 [15SE]

———place restrictions on, and study the impact of, direct-to-consumer advertising of prescription drugs, S7876-S7879, S7886 [1JY]

Public Health Service Act: increase affordability of inpatient drugs for Medicaid and safety net hospitals (S. 1840), S11230 [6OC]

Red Ribbon Week: support goals (S. Res. 277), S11497 [18OC]

Research: expand the clinical trials drug data bank (S. 470), S1797-S1804 [28FE], S13095 [17NO]

Smith, Todd: investigation into murder of journalist in Peru, S4929 [11MY]

Social Security: advertising campaign designed to build public support for privatization proposals, S547 [26JA]

Specter, Senator: report on trip to Cuba, Venezuela, Costa Rica, and Mexico, S10586-S10590 [28SE]

Sports: establish minimum drug testing standards for major professional sports leagues (S. 1114), S5855 [24MY], S6221 [8JN]

———establish minimum drug testing standards for major professional sports leagues (S. 1960), S12345, S12372 [3NO], S12412 [4NO], S12443 [7NO], S12604 [9NO]

———provide for integrity and accountability in professional sports by strengthening testing for performance-enhancing drugs (S. 1334), S7633 [29JN], S7905 [1JY]

States: establish an electronic controlled substances monitoring program in each State (S. 518), S2026 [3MR], S6014 [26MY]

———provide with resources needed to rid our schools of performance-enhancing drug use (S. 1974), S12530 [8NO]

Taxation: allow new investment in, or mergers of biomedical research corporations without limiting tax benefits of net operating losses (S. 1893), S11567 [19OC]

———repeal the medicine and drugs limitation on the deduction for medical care (S. 1514), S9185 [27JY]

Terrorism: prohibit narco-terrorists from aiding and supporting terrorists and terrorist organizations (S. 1642), S9846 [8SE]

———provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack, S14237 [21DE]

———provide incentives to commercial researchers to develop technologies and drugs to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack (S. 975), S4590-S4595, S4607 [28AP], S4787 [9MY], S9433 [29JY], S11602 [20OC]

U.S. Anti-Doping Agency: designate (S. 529), S2044 [3MR]

University of Kentucky: College of Pharmacy recipient of American Pharmacists Association Pinnacle Award, S6469 [14JN]

Uribe, Alvaro: U.S. visit, S10058 [15SE]

Veterans: expand and enhance health care, mental health, transition, and disability benefits (S. 13), S111, S168 [24JA], S510-S512 [26JA]

———health care funding, S2720-S2726 [15MR], S2788-S2793, S2806, S2807 [16MR]

World AIDS Day: observance, S13496 [13DE]

Reports

Scientific Reasons for Methamphetamine Effects, H10375 [16NO]

Reports filed

Biodefense and Pandemic Vaccine and Drug Development Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 1873), S11768 [24OC]

Combat Meth Act: Committee on the Judiciary (Senate) (S. 103), S9282 [28JY]

Consideration of H.R. 1279, Gang Deterrence and Community Protection Act: Committee on Rules (House) (H. Res. 268) (H. Rept. 109-76), H3112 [10MY]

Controlled Substances Export Reform Act: Committee on Energy and Commerce (House) (H.R. 184) (H. Rept. 109-115), H4354 [9JN]

———Committee on the Judiciary (House) (H.R. 184) (H. Rept. 109-115), H5637 [11JY]

Drug Free Sports Act: Committee on Energy and Commerce (House) (H.R. 3084) (H. Rept. 109-210), H7556 [28JY]

Gang Deterrence and Community Protection Act: Committee on the Judiciary (House) (H.R. 1279) (H. Rept. 109-74), H3051 [5MY]

Investigation Into Rafael Palmeiro's Testimony at the Hearing on Evaluating Major League Baseball's Effort To Eradicate Steroid Use: Committee on Government Reform (House) (H. Rept. 109-310), H11032 [18NO]

Lift the Patient Limitation on Prescribing Drug Addiction Treatments by Medical Practitioners in Group Practices: Committee on Energy and Commerce (House) (H.R. 869) (H. Rept. 109-116), H4354 [9JN]

———Committee on the Judiciary (House) (H.R. 869) (H. Rept. 109-116), H5637 [11JY]

Methamphetamine Epidemic Elimination Act: Committee on Energy and Commerce (House) (H.R. 3889) (H. Rept. 109-299), H10908 [17NO]

———Committee on the Judiciary (House) (H.R. 3889) (H. Rept. 109-299), H10501 [16NO]

Methamphetamine Epidemic—International Roots of the Problem, and Recommended Solutions: Committee on Government Reform (House) (H. Rept. 109-352), H12047 [16DE]

Methamphetamine Remediation Research Act: Committee on Science (House) (H.R. 798) (H. Rept. 109-42), H1967 [13AP]

National All Schedules Prescription Electronic Reporting Act: Committee on Energy and Commerce (House) (H.R. 1132) (H. Rept. 109-191), H6932 [27JY]

———Committee on Health, Education, Labor, and Pensions (Senate) (S. 518) (S. Rept. 109-117), S9466 [29JY]

National Drug Control Strategy and Budget: Committee on Government Reform (House) (H. Rept. 109-172), H5962 [18JY]

Office of National Drug Control Policy Reauthorization: Committee on Government Reform (House) (H.R. 2829) (H. Rept. 109-315), H11032 [18NO]

Patient Safety and Quality Improvement Act: Committee on Energy and Commerce (House) (H.R. 3205) (H. Rept. 109-197), H6932 [27JY]

Statements

Gang Deterrence and Community Protection Act: Several Social Justice Organizations, H3130 [11MY]

Medicaid Drug Rebate Program Extension to Enrollees of Managed Care Organizations: American Public Human Services Association, S9508 [29JY]

Rethinking Plan Colombia, H5314 [28JN]

Walter Ginter Recovering Drug Addict: Walter Ginter, E1903 [20SE]

Summaries

American Neighborhoods Taking the Initiative—Guarding Against Neighborhood Gangs (ANTI-GANG) Act (S. 1322), S7527 [28JN]

Medicaid Health Plan Rebate Act (S. 1585), S9507 [29JY]

Patient Safety and Quality Improvement Act (S. 544), S8741 [22JY]

Trade Agreements and Access to Medications Under the Bush Administration: Committee on Government Reform (House), H6926 [27JY]

Tables

Proposed VA budget for fiscal year 2006, S2723 [15MR]

Texts of

H. Res. 208, Salk polio vaccine development anniversary, H2171 [20AP]

H. Res. 261, tribute to Centers for Medicare & Medicaid Services demonstration project to assess quality of care of cancer patients undergoing chemotherapy, H8683 [6OC]

H. Res. 268, consideration of H.R. 1279, Gang Deterrence and Community Protection Act, H3120 [11MY]

H. Res. 485, support goals of Red Ribbon Week, H9058 [25OC]

H.R. 798, Methamphetamine Remediation Research Act, H11462 [13DE]

H.R. 1132, National All Schedules Prescription Electronic Reporting Act, H6681-H6683 [27JY]

H.R. 1279, Gang Deterrence and Community Protection Act, H3144-H3146 [11MY]

H.R. 1790, Child Medication Safety Act, H10185 [15NO]

S. 13, Fulfilling Our Duty to America's Veterans Act, S169-S174 [24JA]

S. 16, Affordable Health Care Act, S184-S204 [24JA]

S. 18, Meeting Our Responsibility to Medicare Beneficiaries Act, S207 [24JA]

S. 45, lift the patient limitation on prescribing drug addiction treatments by medical practitioners in group practices, S232 [24JA], S8501 [19JY], H6679 [27JY]

S. 102, Exile Meth Act, S262 [24JA]

S. 103, Combat Meth Act, S262 [24JA]

S. 109, Pharmaceutical Market Access Act, S278-S282 [24JA]

S. 123, Efficiency in Government Health Care Spending Act, S315 [24JA]

S. 124, repeal Medicare Advantage Regional Plan Stabilization Fund, S316 [24JA]

S. 143, Taste of Our Own Medicine Act, S363 [24JA]

S. 155, Gang Prevention and Effective Deterrence Act, S475-S482 [25JA]

S. 173, Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act, S580 [26JA]

S. 226, Improved Vaccine Supply Act, S741 [1FE]

S. 319, Projects for Assistance in Transition From Homelessness (PATH) Program minimum allotments revision, S1134 [8FE]

S. 345, Medicare Prescription Drug Savings and Choice Act, S1273 [10FE]

S. 399, Internet Pharmacy Consumer Protection Act, S1532-S1534 [16FE]

S. 400, Prevention of Illegally Imported Controlled Substances Act, S1534 [16FE]

S. 430, Arrest Methamphetamine Act, S1650 [17FE]

S. 445, Medicare Prescription Drug Price Reduction Act, S1659 [17FE]

S. 470, Fair Access to Clinical Trials (FACT) Act, S1798-S1803 [28FE]

S. 511, RU-486 Suspension and Review Act, S2020 [3MR]

S. 529, U.S. Anti-Doping Agency, S2044 [3MR]

S. 538, Health Professionals Substance Abuse Education Act, S2162-S2164 [7MR]

S. 544, Patient Safety and Quality Improvement Act, H6673-H6676 [27JY]

S. 566, Medicare Dual Eligible Prescription Drug Coverage Act, S2271 [8MR]

S. 674, provide assistance to combat HIV/AIDS in India, S3056 [17MR]

S. 764, Preserving Access to Affordable Drugs Act, S3487 [12AP]

S. 803, Help Expand Access to Recovery and Treatment (HEART) Act, S3680-S3682 [14AP]

S. 809, Access to Legal Pharmaceuticals Act, S3685 [14AP]

S. 813, negotiate for lower prices for Medicare prescription drugs, S3747 [15AP]

S. 873, Medicare Prescription Drug Savings and Choice Act, S4114 [21AP]

S. 893, Anabolic Steroid Control Act technical corrections, S4162 [25AP]

S. 969, Attacking Viral Influenza Across Nations Act, S4582-S4585 [28AP]

S. 1126, prohibit Federal payment or reimbursement for drugs prescribed to sex offenders for the treatment of sexual or erectile dysfunction, S5933 [25MY]

S. 1137, include dehydroepiandrosterone as an anabolic steroid, S6031 [26MY]

S. 1334, Professional Sports Integrity and Accountability Act, S7906 [1JY]

S. 1395, Controlled Substances Export Reform Act, S8244 [13JY], H6671 [27JY]

S. 1514, OTC Medicine Tax Fairness Act, S9185 [27JY]

S. 1585, Medicaid Health Plan Rebate Act, S9508 [29JY]

S. 1698, Vaccines for the New Millennium Act, S10040-S10043 [14SE]

S. 1798, Medicare Do Not Call Act, S10747 [29SE]

S. 1821, Pandemic Preparedness and Response Act, S11133-S11138 [5OC]

S. 1827, Hospital Price Reporting and Disclosure Act, S11220 [6OC]

S. 1841, Medicare Informed Choice Act, S11231 [6OC]

S. 1873, Biodefense and Pandemic Vaccine and Drug Development Act, S11424-S11433 [17OC]

S. 1893, Biotechnology Future Investment Expansion Act, S11567 [19OC]

S. 1956, Access, Compassion, Care, and Ethics for Seriously Ill Patients (ACCESS) Act, S12355-S12357 [3NO]

S. 1974, Drug Free Varsity Sports Act, S12530 [8NO]

S. 2026, Medicare Prescription Drug Gap Disclosure Act, S12959 [16NO]

S. 2046, National Methamphetamine Information Clearinghouse Act, S13174 [17NO]

S. Con. Res. 49, Medicaid anniversary, S9541 [29JY]

S. Con. Res. 67, urge Japan to honor commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals, S13401, S13403 [18NO]

S. Res. 42, promote initiatives to develop an HIV vaccine, S1063 [7FE]

S. Res. 73, tribute to Enrique (Kiki) Camarena, S2274 [8MR], S2585 [11MR]

S. Res. 101, Salk polio vaccine development anniversary, S3318, S3338 [6AP]

S. Res. 136, National Drug Court Month, S5171, S5181 [12MY]

S. Res. 277, support goals of Red Ribbon Week, S11483, S11498 [18OC]

S. Res. 313, National Methamphetamine Prevention Week, S12852 [15NO]

Tributes

Armstrong, Lance, H7699 [7SE]